Sentence examples for cost subset from inspiring English sources

Given a hypergraph with nonnegative costs on hyperedges, and a weakly supermodular function r : 2V→Z+, where V is the vertex set, we consider the problem of finding a minimum cost subset of hyperedges such that for every set S⊆V, there are at least r(S) hyperedges that have at least one but no all endpoints in S.

Given a graph G="(V,E), capacity and cost functions on E, a root r, a subset T of V of terminals and an integer k, we search for a minimum cost subset E′⊂E, covering T and r, such that the network induced by E′ is (k+1 -survivable: after the removal of any k+1 -survivablestill exists aftersible flow from r theT. We also consideremovalofsibility of protecting anyiven number of edges.

The process of performing cost-sensitive subset evaluation is a very effective method because the error-based methods consider the classification errors as equally likely, which is not the case in all the real-time applications [55, 56].

As discussed before, the DBC codes segment the set of DBCs in a huge number of cost inhomogeneous subsets of care episodes, whereas the care paths segment the episodes in a small number of cost homogeneous subsets.

In the same multivariate context, this paper aims at an extension of the double-sampling strategies to monotone designs accounting for differences between the costs of subsets of covariates.

We used a combination of one-way, and where appropriate, multi-way sensitivity approaches to analyse predicted effects and costs when subsets of parameters were varied.

Cost-utility analysis, a subset of cost-effectiveness analysis, uses a generic measure of benefit, the quality-adjusted life year (QALY), to measure the amount of health benefit associated with an intervention.

Then a matching algorithm runs to find the minimum cost non-conflicting subset of interactions.

The mean 5-year cost for the subset of people >65 years of age, including drug costs, was $44,511 (Canadian dollars).

Training clinicians and patients to recognize and address the anxiety and its source will reduce cost in this subset of patients.

As a secondary outcome, we studied 5-year cumulative costs for the subset of patients >65 years of age, including drug costs.